These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24561200)

  • 1. Deregulation of cell signaling in cancer.
    Giancotti FG
    FEBS Lett; 2014 Aug; 588(16):2558-70. PubMed ID: 24561200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Dysregulated Signaling Pathways in Cancer.
    Nisar S; Hashem S; Macha MA; Yadav SK; Muralitharan S; Therachiyil L; Sageena G; Al-Naemi H; Haris M; Bhat AA
    Curr Pharm Des; 2020; 26(4):429-445. PubMed ID: 31939726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Hippo signaling in cancer stem cells.
    Hao J; Zhang Y; Jing D; Li Y; Li J; Zhao Z
    J Cell Physiol; 2014 Mar; 229(3):266-70. PubMed ID: 24037831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 in development and cancer biology.
    Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer stem cells as a possible source of tumor initiation and progression].
    Puchinskaya MV
    Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer stem cell hypothesis: a guide to potential molecular targets.
    Allegra A; Alonci A; Penna G; Innao V; Gerace D; Rotondo F; Musolino C
    Cancer Invest; 2014 Nov; 32(9):470-95. PubMed ID: 25254602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
    Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
    Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of stem cells in the initiation and development of cancer].
    Pergoł P; Nowak-Stepniowska A; Drela K; Padzik-Graczyk A
    Postepy Biochem; 2013; 59(1):45-52. PubMed ID: 23821942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.
    Tandon I; Waghmode A; Sharma NK
    Curr Cancer Drug Targets; 2019; 19(11):877-884. PubMed ID: 31393247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
    Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
    J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells and cell size: A causal link?
    Li Q; Rycaj K; Chen X; Tang DG
    Semin Cancer Biol; 2015 Dec; 35():191-9. PubMed ID: 26241348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.
    Cooper J; Giancotti FG
    Cancer Cell; 2019 Mar; 35(3):347-367. PubMed ID: 30889378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
    Mimeault M; Batra SK
    Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells.
    Ahmed M; Chaudhari K; Babaei-Jadidi R; Dekker LV; Shams Nateri A
    Stem Cells; 2017 Apr; 35(4):839-850. PubMed ID: 28142204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
    Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
    Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells: never Wnt away from the niche.
    Malanchi I; Huelsken J
    Curr Opin Oncol; 2009 Jan; 21(1):41-6. PubMed ID: 19125017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.
    Wang Z; Li Y; Sarkar FH
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):74-80. PubMed ID: 19951255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
    Pylayeva Y; Guo W; Giancotti FG
    Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.